For the financial year ended 30 June 2026, Pro Medicus reported revenue of AUD 261.7 million, representing growth of 22.9% compared with FY25.
According to BlinkLab's announcement on 11 November 2026, 20 people were recruited for the study, comprising nine with a SHANK2 mutation and 11 unaffected siblings. Of those, eight SHANK2 participants and 10 siblings completed the 15-minute smartphone assessment. Two people could not complete testing …
EFTISARC-NEO is testing efti in combination with KEYTRUDA (pembrolizumab) and radiotherapy as a neoadjuvant treatment, meaning it is given before an operation to remove the tumour. According to Immutep's release dated 11 November 2026, the survival data come from 38 evaluable patients with a …
Singular Health Group Limited (ASX:SHG) listed an announcement on 13 January 2026 confirming US Food and Drug Administration 510(k) clearance for 3DICOM MD Cloud. The clearance is relevant to the specific product and permitted regulatory pathway described in that filing. It should not be …
Twenty participants were recruited through the SHANK2 Foundation: nine individuals with a SHANK2 mutation and eleven unaffected siblings, of whom eight and ten respectively completed the 15-minute smartphone assessment. These were compared against a matched community group of 99 participants using the same experimental …
Two items stand out in the 20 October release. The first is the proposed merger with ITM, a radiopharmaceutical group focused on therapy. A further contingent payment of up to US$700 million is linked to regulatory and commercial milestones for ITM-11. Closing requires TelixShareholderapproval, …
Sonic is a global medical diagnostics company. Its core is clinical pathology (laboratory testing ordered by doctors), supplemented by radiology and other medical services in several countries. Revenue arises from testing volumes and the prices or fees paid by government health programs, insurers and …
Ramsay operates private hospitals and related services in three regions. Australia runs private acute hospitals, whereRevenuedepends on patient volumes, the doctors who admit patients (visiting medical officers) and funding from private health insurers. The United Kingdom includes Ramsay UK, which treats NHS and private …
The travel sale is the key structural change. According to the company, the sale of the nib Travel businesses is expected to complete in 1H27 and to deliver about A$97 million of net cash, of which about A$24 million funds a special dividend. The …
DAYBUE royalty income: US$23.3 million, up 29 per cent in US dollars.